Standout Papers

BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Gro... 1994 2026 2004 2015 1.1k
  1. BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth (1999)
    Pascal Schneider, Fabienne Mackay et al. The Journal of Experimental Medicine
  2. Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape (1996)
    Michael Hahne, Donata Rimoldi et al. Science
  3. Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation (2011)
    Greta Guarda, Marion Braun et al. Immunity
  4. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. (1994)
    Béatrice Gaugler, Benoı̂t Van den Eynde et al. The Journal of Experimental Medicine
  5. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients (2011)
    Lukas Baitsch, Petra Baumgaertner et al. Journal of Clinical Investigation
  6. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909 (2005)
    Daniel E. Speiser, Danielle Líénard et al. Journal of Clinical Investigation
  7. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy (2019)
    Xiaoyun Li, Mathias Wenes et al. Nature Reviews Clinical Oncology
  8. Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients (2015)
    Emanuela Romano, Monika Kusio-Kobiałka et al. Proceedings of the National Academy of Sciences
  9. The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis (2014)
    Roberto Lande, Elisabetta Botti et al. Nature Communications
  10. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function (2019)
    Selena Viganó, Dimitrios Alatzoglou et al. Frontiers in Immunology
  11. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases (2024)
    Yang Zhao, Jiangqing Chen et al. Nature Biotechnology
  12. Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision (2024)
    Leisha A. Emens, Pedro Romero et al. Journal for ImmunoTherapy of Cancer

Immediate Impact

17 by Nobel laureates 29 from Science/Nature 102 standout
Sub-graph 1 of 20

Citing Papers

Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience

Works of Pedro Romero being referenced

IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
2024 Standout
CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Pedro Romero 19634 9622 8478 338 26.2k
Nina Bhardwaj 20297 7496 8064 325 27.0k
Daniel E. Speiser 16543 10550 6235 306 22.6k
Gosse J. Adema 16594 7036 9217 312 25.5k
Giorgio Parmiani 14187 10425 9920 420 23.0k
Mario P. Colombo 14887 8351 7488 349 23.8k
Dario A.A. Vignali 22323 11782 6782 238 32.3k
Donald Metcalf 13413 8580 12296 300 30.0k
Rolf Kiessling 16619 7212 5401 310 22.6k
Ian Clark‐Lewis 14662 11986 9854 202 29.4k
Sjoerd H. van der Burg 16734 10403 7013 333 23.0k

All Works

Loading papers...

Rankless by CCL
2026